NOVO NORDISK POSTDOCTORAL RESEARCH FELLOW (2014-2018)
- Project: The effect of metformin on hepatic fatty acid partitioning: an investigation using human in vivo and in vitro cellular models
Charlotte was awarded a Novo Nordisk Postdoctoral Research Fellowship in 2014, working with Professor Leanne Hodson at the Oxford Centre for Diabetes, Endocrinology & Metabolism (OCDEM). The focus of her fellowship involved understanding the impact metformin, an anti-diabetic drug, has on liver fat content in humans and understanding the mechanisms by which any changes may occur. This work has used a combination of in vitro and whole body human in vivo studies.
Charlotte completed her fellowship in 2018 and moved back to Dundee where her scientific career began as Scientific Liaison for the University’s Drug Discovery Unit (DDU). In August 2022 she was promoted to Head of Business development and leads the development and implementation of the Business strategy for the DDU across all its portfolios. Working closely with the Commercialisation Team in the University of Dundee Research and Innovations Services to help commercialise relevant opportunities through licencing deals, spin-out companies and industry collaborations.
Of mice and men: is there a future for metformin in the treatment of hepatic steatosis?
Green CJ., Marjot T., Tomlinson JW., Hodson L (2018) Diabetes, Obesity and Metabolism
Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models
Green CJ., Parry SA., Gunn PJ., Ceresa CDL., Rosqvist F., Piché ME., Hodson L (2018) Hormone Molecular Biology and Clinical Investigation
The isolation of primary hepatocytes from human tissue: optimising the use of small non-encapsulated liver resection surplus
Green CJ., Charlton CA., Wang LM., Silva M., Morten KJ., Hodson L (2017) Cell Tissue Bank